These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17642248)

  • 21. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Update of the guidelines of the Israeli Association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers].
    Balbir-Gurman A; Lidgi M; Elkayam O
    Harefuah; 2014 Jun; 153(6):359-61, 366. PubMed ID: 25095612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers.
    Bellofiore B; Matarese A; Balato N; Gaudiello F; Scarpa R; Atteno M; Bocchino M; Sanduzzi A
    J Rheumatol Suppl; 2009 Aug; 83():76-7. PubMed ID: 19661550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
    Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
    J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers.
    Cobanoglu N; Ozcelik U; Kalyoncu U; Ozen S; Kiraz S; Gurcan N; Kaplan M; Dogru D; Yalcin E; Pekcan S; Kose M; Topaloglu R; Besbas N; Bakkaloglu A; Kiper N
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1177-82. PubMed ID: 17958978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
    Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
    Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of latent tuberculosis infection: the potential role of new technologies.
    Kunst H
    Respir Med; 2006 Dec; 100(12):2098-106. PubMed ID: 16650976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test.
    Silva LC; Geluk A; Arnone M; Romiti R; Franken KC; Duarte AJ; Takahashi MD; Benard G
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):319-24. PubMed ID: 21623925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
    Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
    Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guidelines of the Israeli association of rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers].
    Elkayam O; Balbir-Gurman A; Lidgi M; Rahav G; Weiler-Ravel D
    Harefuah; 2007 Mar; 146(3):235-7, 244. PubMed ID: 17460934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive therapy and tuberculosis].
    Yoshikawa K; Yano S
    Kekkaku; 2010 Jan; 85(1):33-45. PubMed ID: 20232543
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
    Lee SS; Liu YC; Huang TS; Chen YS; Tsai HC; Wann SR; Lin HH
    Scand J Infect Dis; 2008; 40(5):373-80. PubMed ID: 18418798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.
    Vilaplana C; Ruiz-Manzano J; Gil O; Cuchillo F; Montané E; Singh M; Spallek R; Ausina V; Cardona PJ
    Scand J Immunol; 2008 Jun; 67(6):610-7. PubMed ID: 18397200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay.
    Dinser R; Fousse M; Sester U; Albrecht K; Singh M; Köhler H; Müller-Ladner U; Sester M
    Rheumatology (Oxford); 2008 Feb; 47(2):212-8. PubMed ID: 18208824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
    Winthrop KL
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.